CLXN -hat weltweite exclusivrechte TyroTest Pharma


Seite 1 von 3
Neuester Beitrag: 09.10.08 00:05
Eröffnet am:03.10.08 14:40von: MB240Anzahl Beiträge:65
Neuester Beitrag:09.10.08 00:05von: jocyxLeser gesamt:17.742
Forum:Hot-Stocks Leser heute:2
Bewertet mit:
2


 
Seite: < 1 | 2 | 3 >  

31 Postings, 5656 Tage MB240CLXN -hat weltweite exclusivrechte TyroTest Pharma

 
  
    #1
2
03.10.08 14:40

CLXN - Has aquired worldwide exclusive Rights to the ThyroTest Pharma.This is a United on the International Pharma Market, and i will bring CLX Medical a Great Great Performances, Big Profit will come $$$$$$ The Share Price of CLXN will we extremely explode.A Big Run will come.
I have more Informtions.his is my Advantage - I will not said it.I will definetly buy more and more of CLXN Stocks, which makes e Rich and othe Investors make rich $$$$$$$$$$$$$$$$$$$$$$$$

CLXN - The $.10 will come.Thats Defenitly correct.Yea. will by more and will catch tommorrow more stocks and by mo9re and more.
I have more Infom´formations too.

In the folling here a actuelle News from 17.09.2008, 23.09.2008, 25.08.2009 and the Interview betwen Q & A and Vera Leonard, CEO of CLXN Medical with futere Targets.The Huge Great Next News will come as soon:


The News from 17.09.2008:
$$$$$$$$$$$$$$$$$$$$$$$$$

CLX Medical, Inc. - CLXN

--------------------------------------------------

CLX Medical, Inc. Files Form 8-K on Definitive Agreement for the Acquisition of the ThyroTest(R) Rapid Screening Device

2008-09-17 10:02 ET - News Release

MURRIETA, CA -- (MARKET WIRE) -- 09/17/08

CLX Medical, Inc. (OTCBB: CLXN), which is focused on the marketing and distribution of unique medical diagnostic testing products, has filed a Current Report on Form 8-K regarding its planned purchase of ThyroTest®, a rapid thyroid stimulating hormone (TSH) screening device used for the detection of hypothyroidism in adults, a common thyroid disease.

The Form 8-K can be accessed through a link to SEC filings in the "Corporate" section of the CLX Medical website, CLX MEDICAL INC..

The Form 8-K reports that on September 9, 2008, CLX Medical entered into a product purchase agreement with ThyroTec, LLC, the developer of the ThyroTest® device, pursuant to which CLX Medical will acquire from ThryoTec the exclusive, worldwide rights to ThyroTest®, together with related packaging and marketing materials. The purchase price for the acquisition consists of a cash payment of $750,000 upon closing and the issuance of Series C convertible preferred stock of CLX Medical convertible into fifteen percent (15%) of the total, fully-diluted common stock of the company.

Upon closing, Jim Small, ThyroTec's chief executive officer, or his designate will be appointed as a member of CLX Medical's board of directors. Mr. Small has 30 years of thyroid related pharmaceutical experience and is the co-founder of ThyroTec.


The News from 23.09.2008:
$$$$$$$$$$$$$$$$$$$$$$$$$


Re: CLX Medical, Inc. Files Form 8-K on Definitive Agreement for the Acquisition of the ThyroTest(R

--------------------------------------------------

Press Release Source: CLX Medical, Inc.
CLX Medical, Inc. Announces Long Term Employment Agreement
with CEO Vera Leonard
Issued Tuesday September 23, 9:36 am ET
MURRIETA, CA--(MARKET WIRE)--Sep. 23, 2008 -- CLX Medical, Inc. (OTC BB:
CLXN), which is focused on the marketing and distribution of unique medical diagnostic
testing products, today announced a three year employment agreement with Chief
Executive Officer Vera Leonard.
Ms. Leonard’s compensation package includes a combination of a base salary, a schedule
of salary increases based on a variety of factors including the company’s revenue and
profit performance, the granting of restricted common stock, medical coverage, and
expense reimbursements. Ms. Leonard’s full employment agreement will be filed as an
exhibit to the company’s annual report for the fiscal year ending September 30, 2008.
The employment contract was executed as CLX prepares to close the acquisition of
ThyroTest®, a rapid thyroid stimulating hormone (TSH) screening device used for the
detection of hypothyroidism in adults, a common thyroid disease.
On September 9, 2008, CLX Medical entered into a product purchase agreement with
ThyroTec, LLC, the developer of the ThyroTest® device, pursuant to which CLX
Medical will acquire from ThryoTec the exclusive, worldwide rights to ThyroTest®. In
addition to working to close the transaction, Ms. Leonard and CLX Medical management
is focused on the execution of a post-acquisition marketing and distribution plan for
ThyroTest®.
“I am pleased to have reached agreement on a long term employment agreement with the
CLX Medical board and look forward to the successful implementation of our strategy to
build value for CLX Medical shareholders,” stated Ms. Leonard. “The pending
acquisition of ThyroTest® is expected to be a major milestone in our efforts to establish
value in the company based on revenues from worldwide sales of this device and
additional products that may be distributed in the future.”
Robert McCoy, chairman of CLX Investment Company, commented, “The Board
believes that Ms. Leonard is the right person to implement the marketing and distribution
strategy for ThyroTest®, and the execution of this employment agreement, which ties
increases in her compensation to the revenue and profit performance of CLX Medical, is
the right step for the company at this time. We look forward to seeing the further
development of CLX Medical under her leadership.”
ThyroTest® is FDA cleared and has also achieved CLIA waived status, so the test can be
administered in the more than 100,000 CLIA waived doctor’s offices in the U.S., as well
as in any non-waived laboratory. The simple rapid diagnostic test is a qualitative
measurement that allows physicians to screen adult patients for hypothyroidism in
approximately ten minutes with a whole blood sample.
To sign up to receive information by email directly from CLX Medical, Inc. when new
press releases, investor newsletters, SEC filings, or other information is disclosed, please
visit CLX MEDICAL INC..
About CLX Medical, Inc.
CLX Medical, Inc. (CLX MEDICAL INC.) holds a 51% equity interest in Zonda, Inc.
(Zonda Incorporated - Official Web Site), which has developed several rapid point of care tests for
medical and non-medical markets, including a rapid test for chlamydia. CLX has also
entered into a definitive agreement to acquire ThyroTest®, a rapid thyroid stimulating
hormone (TSH) screening device used for the detection of hypothyroidism in adults, a
common thyroid disease. CLX Medical is focused on the successful worldwide
distribution of these and any additional products it may acquire or license.
All statements included in this release, including statements regarding potential future plans and objectives
of CLX Medical, Inc. are forward-looking statements. Such statements are necessarily subject to risks and
uncertainties, some of which are significant in scope and nature beyond CLX Medical’s control. There can
be no assurance that such statements will prove accurate. Actual results and future events could differ
materially from those anticipated in such statements depending on many factors. Historical results are not
necessarily indicative of future performance.
Contact:
Gemini Financial Communications, Inc.
A. Beyer
951-677-8073
investors@clxmedical.com


Moderation
Zeitpunkt: 04.10.08 01:49
Aktion: Nutzer-Sperre für immer
Kommentar: Doppel-ID - von GuruJoe1

 

 
39 Postings ausgeblendet.
Seite: < 1 | 2 | 3 >  

4951 Postings, 6013 Tage 0815ax...dann mach es & leg nicht immer neue ID's an !!

 
  
    #41
5
05.10.08 15:32

14 Postings, 5655 Tage Lambo60CLXN - Auf Long

 
  
    #42
2
05.10.08 15:41

14 Postings, 5655 Tage Lambo60Löschung

 
  
    #43
05.10.08 16:47

Moderation
Zeitpunkt: 05.10.08 17:10
Aktionen: Löschung des Beitrages, Nutzer-Sperre für 2 Stunden
Kommentar: Pushversuch

 

 

14 Postings, 5655 Tage Lambo60Löschung

 
  
    #44
1
05.10.08 16:48

Moderation
Zeitpunkt: 06.10.08 20:04
Aktionen: Löschung des Beitrages, Nutzer-Sperre für 7 Tage
Kommentar: Doppel-ID - Anlage u. Führen einer Doppel-ID DR.Vision  (zum 3. mal !!!)

 

 

15572 Postings, 6167 Tage nekroChlamydien......lecker...........?????????;-))))))

 
  
    #45
4
05.10.08 17:40
Ich will garnicht wissen,wieviele von den Dingern ich schon intus habe :-((((((((((((((((((((((((((((((

Als Chlamydiengegner werde ich mir den Share mal unter die Lupe nehmen,(Filings,Herkungt,Financials etc.)

Schliesslich : Auch ein Dummpush kann gewinnbringend sein.;-))))))))))))))))  

4 Postings, 5654 Tage InsiderJoeLöschung

 
  
    #46
1
05.10.08 20:27

Moderation
Zeitpunkt: 05.10.08 23:08
Aktionen: Löschung des Beitrages, Nutzer-Sperre für immer
Kommentar: Doppel-ID - v. Lambo60

 

 

4 Postings, 5654 Tage InsiderJoeInteressant Interessant - Es wissen einige mehr $$

 
  
    #47
1
05.10.08 20:34

Revolutionärer Produkt, Patentiert , Welt - Eine Perle $$$$

For additional details regarding Sentry's capabilities and services, please visit http://www.sentrylogistic.com/services.php.

IIT Research Institute (IITRI) (http://www.iitri.org) will serve as the laboratory that will conduct a validation study for Zonda's rapid point of care test for chlamydia.

AHP (http://www.ahpartners.com) has over 30 years of experience in the marketing and distribution of professional medical products and has experience in preparing products for market launch in the United States.

Safis Solutions (http://www.safis-solutions.com), an Indianapolis-based regulatory compliance consulting company serving pharmaceutical, medical device and biotech companies worldwide, has been retained as a sub-contractor of American Health Partners, LLC (AHP), which has been engaged by CLX to assist with the launch of medical diagnostic testing products in its subsidiary operations. Safis Solutions is providing ongoing consulting services in the areas of regulatory approvals and quality systems for Zonda and additional potential future medical diagnostic technologies acquired by CLX.

Trial Care International, LLC (http://trialcareintl.com/index.html) specializes in the management of Phase I-IV clinical trials in a wide range of therapeutic areas and provides clinical management, monitoring, auditing and regulatory services to the pharmaceutical and biotech industry through partnering and long-term relationships with its clients.

4/30/08 LOI for FDA approved CLIA waived test kit

CLXN announced that after a period of initial due diligence and negotiations, the company has progressed to a letter of intent to acquire a rapid diagnostic device for the medical market.

The due diligence process will continue as CLX pursues a definitive agreement and the close of the acquisition of the device. Once CLX has reached a mutually agreed upon point in its due diligence process, it will announce the name of the device and the market that it serves.

The acquisition target presents considerable synergies with the product line of Zonda, Incorporated, a majority owned subsidiary of CLX that has developed a rapid point of care test for chlamydia. CLX is currently preparing to initiate clinical trials for the Zonda chlamydia test as part of the effort to achieve FDA clearance for the product. The company recently announced a validation study to perfect the testing protocol in preparation for the clinical trials.

:) 2008 UPDATED PRODUCT LAUNCHES!!!! :)

Chlamydia: - Clinical trials underway for FDA clearance. Targeted to Launch at the end of Q2 2008

Gonorrhea: - Targeted to Launch Q3 2008

Strep-A: - Targeted to Launch Q3 2008

Yeast: - Targeted to Launch Q3 2008

Get the latest NEWS Releases:
http://finance.yahoo.com/q?s=CLXN.OB

Get the Latest SEC info:
http://finance.yahoo.com/q/sec?s=CLXN.OB

Get the Latest Company Events:
http://finance.yahoo.com/q/ce?s=CLXN.OB

FACTS ABOUT HandiLab

*Rapid
*Self-Contained
*Point of Care and OTC (self testing)
...... Dianostic System

Core technology

Proprietary enzyme detection system (patent pending) consisting of a synthetic substrate which, in the presence of an enzyme specific to the infectious disease, causes a chemical reaction.

This reaction, when coupled to a developing agent, causes a color to appear on the tip of the swab.

Competing Technologies to HandiLab

*Culture
*Nucleic Acid Probe
*Antigen Detection
*Polymerase Chain Reaction (PCR)

Advantages of HandiLab

*NOequipment needed
*NOexpensive instrumentation necessary
*NOadditional reagents to store
*NOoff-line extraction; self-contained
*NOexpensive employee training
*3easy steps
*FASTresults at point-of-care
*DIAGNOSEand treat patients in same visit

Customers for HandiLab

Point of Care - Doctors Offices
Laboratories
Public health/STD Clinics
University Health Clinics
Over The Counter (OTC) Pharmacies

What does CLIA waived mean?

http://www.fda.gov/cdrh/clia/cliawaived.html

A list of CLIA waived tests since 2000:

http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/.../testswaived.cfm

 

 

 
Angehängte Grafik:
hadi-lab-c-clx_medical_produkt.jpg
hadi-lab-c-clx_medical_produkt.jpg

4 Postings, 5654 Tage InsiderJoe@nekro Hast du schon weitere Infos

 
  
    #48
2
06.10.08 12:52

15572 Postings, 6167 Tage nekroDas.....

 
  
    #49
2
06.10.08 13:41
Cash and Cash Equivalents at End of Period   15,122 $

....hat mir schon gereicht ;-)))))))))

http://yahoo.brand.edgar-online.com/...=sect&dcn=0001262463-08-000120  

4 Postings, 5654 Tage InsiderJoeMittwoch nach 20.00 Uhr MEZ News HHHHMMMM $$$$

 
  
    #50
1
06.10.08 15:33


Moderation
Zeitpunkt: 06.10.08 15:34
Aktion: Nutzer-Sperre für immer
Kommentar: Doppel-ID

 

 

4 Postings, 5653 Tage DR.VisionLöschung

 
  
    #51
06.10.08 19:45

Moderation
Zeitpunkt: 06.10.08 20:03
Aktionen: Löschung des Beitrages, Nutzer-Sperre für immer
Kommentar: Doppel-ID - von Lambo60

 

 

4 Postings, 5653 Tage DR.VisionCLXN = 100Bagger.Manche wissen mehr $$$$

 
  
    #52
06.10.08 19:46
Schnell rein  

4 Postings, 5653 Tage DR.VisionLöschung

 
  
    #53
06.10.08 19:48

Moderation
Zeitpunkt: 06.10.08 20:05
Aktion: Löschung des Beitrages
Kommentar: Pushversuch

 

 

4 Postings, 5653 Tage DR.VisionCLXN - ERstes Kursziel 0,10 US$= CLXN Strong Buy

 
  
    #54
06.10.08 19:51
Bei dem jetzigen Kurs ist es eine Performance von = 200.000 % = 200Bagger.WOOOWW

$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$  

15572 Postings, 6167 Tage nekroLast Trade: 0.0002 USD

 
  
    #55
07.10.08 00:27
Bid: 0.0001 x 5000

Ein BID von einem halben USD?????????????

VOL heute 4.903716 St a 0,0002 macht Waaaahnsinns 980,74 USD Umsatz ;-)))))))))))))))

Da ziehen sich ja sogar die Chlamydien......in ihr "Schneckenhaus" zurück ;-)))))))))))  

58056 Postings, 6003 Tage jocyxAber es ist doch eine Leistung

 
  
    #56
07.10.08 00:37
ruck zuck über 50 Postings zu diesem Müll unterzubringen. Oder habe ich da aus Versehen was Fundamentales übersehen ...

15572 Postings, 6167 Tage nekroKein Problem.............

 
  
    #57
07.10.08 05:24
....wenn sich eine gespaltene Persönlichkeit mit Multi IDs mit sich selbst unterhält :-((((((((((((

Wird jemand mit Doppel-oder Multi IDs erwischt,so sollten ihm sofort alle IDs gesperrt u. Neuanmeldungen unterbunden werden.

 

3816 Postings, 7060 Tage flumi4Finger weg!

 
  
    #58
07.10.08 06:35
diese Aktie wird per Spam beworben!  

2 Postings, 5652 Tage SeniorTraderCLXN - An der Story ist wohl was drann.Ich kaufe

 
  
    #59
1
07.10.08 10:35
Ich kaufe CLXN - CLX Medical.ZU dem dazu und ein Basher würde niemals eine schlechte Aktie baschen,Nicht war.
Das haben Leute bei MONA, Früher EFGO auch die Leute gesagt, und die Leute konnten nicht genug von der Aktie reden.Halb IHUB redet schon davon.Ich lass mich auch von dir flummi nicht beeinflussen.Ich werde CLXN kaufen und dazu stehe Ich.Jeder ist sein eigene Hirn, und wo kämen wir da hin, wenn wir uns von jem flumi beinflussen lassen würden.Un d Ich stehe dazu.An der Story  ist was drann, HHHMM das riecht nur nur hohe Prozente und Gewinnsteigerungen im extgremen.  

58056 Postings, 6003 Tage jocyxschon wieder neue ID ?

 
  
    #60
1
07.10.08 10:43

2 Postings, 5652 Tage SeniorTraderLöschung

 
  
    #61
07.10.08 10:47

Moderation
Zeitpunkt: 07.10.08 10:55
Aktionen: Löschung des Beitrages, Nutzer-Sperre für immer
Kommentar: Doppel-ID - von Lambo60

 

 

58056 Postings, 6003 Tage jocyxnurmal zur Info was das ist

 
  
    #62
07.10.08 11:03
der Kurs ist Null:
Angehängte Grafik:
clxn_kl.gif
clxn_kl.gif

214 Postings, 5667 Tage Biegelin detschland nur 3stellen

 
  
    #63
08.10.08 19:32
0,0002  

15572 Postings, 6167 Tage nekroHat heute in USA 50% gemacht..........

 
  
    #64
1
08.10.08 23:57
.......Miese natürlich ;-))))))))))))))))))))

http://finance.yahoo.com/q?s=CLXN.OB

VOL 105 Mio St

Umsatz 10581,3 USD
 

58056 Postings, 6003 Tage jocyxHatte nur die Überschrift gelesen

 
  
    #65
09.10.08 00:05
aber dann auch den Rest. Also alles wie gehabt.

Seite: < 1 | 2 | 3 >  
   Antwort einfügen - nach oben